Gesynta Pharma
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several serious diseases.
$28M Series B+ ·
Led by Innovestor · Source: fundraisingfox.com
Latest round on record: Series B+, July 2025, amount undisclosed.
All 2 rounds ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com | |
| Series B+ | $28M | fundraisingfox.com |
Timeline
- Website created
Founders and team
PS
Patric Stenberg Founder
Investors
AAmboy Street Ventures
CCatalyze Capital
FForeground Capital
HHadean Ventures
HHealthCap
IIndustrifonden
IInnovestorlead investor
- LLinc
SStephen Industries
XXGEN Venture
Companies like Gesynta Pharma
AAugustine Therapeutics$85M Series A · Mar 2025
AAmplio PharmaSeed · Oct 2026
QQubit PharmaceuticalsSeed · Jun 2022
CCambridge Epigenetix$88M Series B+ · Nov 2021
CCyllene Therapeutics$37M Series B+ · Jul 2026
NNakad$7M Seed · May 2022
Other companies backed by Innovestor
AAnaCardio$70.97M Series B+ · Sep 2026
BBreye Therapeutics$76.65M Series A · Sep 2026
CCapalo AI$12.97M Series A · Feb 2026
AActithera$75.5M Series A · Jul 2025
KKhoySeed · Sep 2026
TTribune Therapeutics ABSeries A · Mar 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gesynta-pharma (get a free API key).